PFKL Protein
<div class="infobox infobox-protein">
| Property | Value |
|---|---|
| Protein Name | Phosphofructokinase, Liver (PFKL) |
| Gene | PFKL |
| UniProt | P31182 |
| PDB | 4XON, 5AUY |
| Molecular Weight | ~780 kDa (tetramer) |
| Subcellular Localization | Cytoplasm |
| Protein Family | Phosphofructokinase family |
| EC Number | 2.7.1.11 |
</div>
Overview
PFKL (Phosphofructokinase, Liver) is a key glycolytic enzyme that catalyzes the third and rate-limiting step of glucose metabolism. The enzyme phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate, utilizing ATP as a phosphate donor. PFKL is the liver-specific isoform of phosphofructokinase, encoded by the PFKL gene located on chromosome 10q22.3. The protein exists as a homotetrameric complex under physiological conditions, with each subunit containing approximately 784 amino acids. While primarily characterized for its role in hepatic metabolism, emerging research has identified PFKL's involvement in neuronal energy homeostasis and its potential contribution to neurodegenerative disease pathophysiology[@pmid38773347].
Function and Biology
...PFKL Protein
<div class="infobox infobox-protein">
| Property | Value |
|---|---|
| Protein Name | Phosphofructokinase, Liver (PFKL) |
| Gene | PFKL |
| UniProt | P31182 |
| PDB | 4XON, 5AUY |
| Molecular Weight | ~780 kDa (tetramer) |
| Subcellular Localization | Cytoplasm |
| Protein Family | Phosphofructokinase family |
| EC Number | 2.7.1.11 |
</div>
Overview
PFKL (Phosphofructokinase, Liver) is a key glycolytic enzyme that catalyzes the third and rate-limiting step of glucose metabolism. The enzyme phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate, utilizing ATP as a phosphate donor. PFKL is the liver-specific isoform of phosphofructokinase, encoded by the PFKL gene located on chromosome 10q22.3. The protein exists as a homotetrameric complex under physiological conditions, with each subunit containing approximately 784 amino acids. While primarily characterized for its role in hepatic metabolism, emerging research has identified PFKL's involvement in neuronal energy homeostasis and its potential contribution to neurodegenerative disease pathophysiology[@pmid38773347].
Function and Biology
PFKL functions as a metabolic checkpoint enzyme, controlling glucose flux through glycolysis based on cellular energy status and metabolic demands. The enzyme exhibits allosteric regulation, responding to adenosine nucleotides (ATP, AMP), citrate, and pH changes. High ATP and citrate concentrations inhibit PFKL activity, while AMP and low pH activate the enzyme—a mechanism ensuring ATP production matches cellular consumption rates.
The protein operates within the cytoplasm, where it encounters its substrates as part of the sequential glycolytic cascade. PFKL shares structural homology with other phosphofructokinase isoforms (PFKM in muscle and PFKP in platelet-type), yet possesses distinct kinetic properties and regulatory characteristics suited to hepatic metabolic requirements. The liver isoform exhibits intermediate ATP sensitivity compared to muscle and platelet forms, reflecting the liver's role in both energy storage and gluconeogenic pathways.
PFKL participates in metabolic crosstalk by responding to signals indicating energy sufficiency or deficiency. During fed states, elevated glucose-6-phosphate levels promote PFKL activity, facilitating glucose oxidation and lipogenesis. During fasting, reduced PFKL activity redirects glucose toward gluconeogenesis and glycogen synthesis, demonstrating the enzyme's integration within broader metabolic networks.
Role in Neurodegeneration
Recent research has implicated impaired glucose metabolism in multiple neurodegenerative diseases, positioning PFKL as a potential contributor to pathological processes. Neurons depend almost exclusively on glucose oxidation for ATP generation, making glycolytic dysfunction particularly deleterious to neural tissue. Emerging evidence suggests that altered PFKL expression or activity may compromise neuronal energy production, particularly in conditions involving mitochondrial dysfunction.
PFKL dysregulation has been observed in post-mortem analyses of Alzheimer's disease and Parkinson's disease brains, where glycolytic enzyme expression changes correlate with pathological burden. Reduced PFKL activity would impair ATP generation during periods of increased neuronal demand, potentially sensitizing neurons to metabolic stress and accelerating degeneration. Additionally, glycolytic dysfunction may promote alternative ATP-generating pathways or shift neurons toward less efficient energy production modes, exacerbating cellular vulnerability to age-related challenges.
Molecular Mechanisms
PFKL dysfunction in neurodegeneration may occur through multiple mechanisms. Amyloid-beta accumulation in Alzheimer's disease can impair mitochondrial function, increasing neuronal dependence on glycolytic ATP production and potentially overwhelming inadequate PFKL-mediated glucose processing capacity. Oxidative stress, prevalent in neurodegenerative conditions, may directly damage PFKL through reactive oxygen species-mediated modifications of critical cysteine residues or through proteasomal degradation.
Post-translational modifications, including phosphorylation and ubiquitination, regulate PFKL stability and activity. Dysregulated kinase or phosphatase activity in neurodegenerative disease could alter PFKL phosphorylation patterns, reducing enzymatic efficiency. Additionally, impaired proteostasis characteristic of neurodegeneration may lead to PFKL aggregation or degradation.
Clinical and Research Significance
PFKL represents an emerging target for understanding metabolic contributions to neurodegeneration. Therapeutic strategies targeting glycolytic efficiency through PFKL modulation could potentially support neuronal energy homeostasis in disease contexts. Biomarker studies examining PFKL levels in cerebrospinal fluid or neuroimaging assessment of brain glucose metabolism may provide diagnostic or prognostic value.
- PFKM - Muscle isoform of phosphofructokinase